Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 125 of 401 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/21/10
End: 04/17/19
Due: 04/17/20
Phase: N/A
Priority: Normal
Start: 04/30/14
End: 07/31/16
Due: 07/31/17
Phase: N/A
Priority: Normal
Start: 05/31/12
End: 11/30/14
Due: 11/30/15
Phase: N/A
Priority: Normal
Start: 04/30/23
End: 04/30/23
Due: 04/30/24
Phase: N/A
Priority: Normal
Start: 01/31/10
End: 03/31/11
Due: 03/31/12
The Brigance Assessment Of Individual Neurodevelopment In Young Children With Sickle Cell Disease- 2
Phase: N/A
Priority: Normal
Start: 05/31/10
End: 05/31/15
Due: 05/31/16
Phase: N/A
Priority: Normal
Start: 02/29/96
End: 06/30/01
Due: 06/30/02
Phase: N/A
Priority: Normal
Start: 05/14/24
End: 10/31/28
Due: 10/31/29
Phase: N/A
Priority: Normal
Start: 06/30/25
End: 01/31/28
Due: 01/31/29
Phase: N/A
Priority: Normal
Start: 02/07/20
End: 12/31/27
Due: 12/31/28
Phase: N/A
Priority: Normal
Start: 06/08/00
End: 05/31/45
Due: 05/31/46
Phase: N/A
Priority: Normal
Start: 08/31/03
End: 02/28/09
Due: 02/28/10
Phase: N/A
Priority: Normal
Start: 09/30/09
End: 06/30/15
Due: 06/30/16
Phase: N/A
Priority: Normal
Start: 09/02/21
End: 07/01/28
Due: 07/01/29
Phase: N/A
Priority: Normal
Start: 07/31/14
End: 06/30/16
Due: 06/30/17
Phase: N/A
Priority: Normal
Start: 10/16/24
End: 07/01/31
Due: 07/01/32
Phase: N/A
Priority: Normal
Start: 10/31/96
End: 06/30/07
Due: 06/30/08
Phase: N/A
Priority: Normal
Start: 02/28/13
End: 04/30/14
Due: 04/30/15
Phase: N/A
Priority: Normal
Start: 11/30/12
End: 03/31/14
Due: 03/31/15
Phase: N/A
Priority: Normal
Start: 10/18/13
End: 05/31/17
Due: 05/31/18
Phase: N/A
Priority: Normal
Start: 07/26/22
End: 01/31/35
Due: 01/31/36
Phase: N/A
Priority: Normal
Start: 07/25/23
End: 03/31/34
Due: 03/31/35
Phase: N/A
Priority: Normal
Start: 08/20/12
End: 02/10/20
Due: 02/10/21
Phase: N/A
Priority: Normal
Start: 11/15/21
End: 06/30/27
Due: 06/30/28
Phase: N/A
Priority: Normal
Start: 07/08/24
End: 02/28/26
Due: 02/28/27